Purchase Order 75N91020K20055
Award Date 9/22/20
Potential Completion Date 12/27/23
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $15,000 purchase order to 10X Genomics, Inc. for service agreement work. 10X Genomics will perform the services at its Pleasanton, California location from September 2023 through September 2024 under a firm fixed price contract. No additional details were provided on the scope of work requested under the solicitation. The National Cancer Institute supports research to advance cancer...
- The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a Blanket Purchase Agreement Call contract to 10X Genomics, Inc. of Pleasanton, California. With a completion date of December 26, 2023 and awarded on September 8, 2023, this firm fixed price contract has a potential value of $0.00. No set-aside designation was used. As a leading provider of solutions for single-cell analysis, 10X Genomics will likely support the NCI's cancer research...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,116 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for biological kits. 10X Genomics will deliver the requested biological kits to support the NIH NCI's research efforts under this one month contract based in Pleasanton, California. As a leading developer of single-cell solutions, 10X Genomics is well positioned to provide these products to further...
- The National Cancer Institute awarded a $23,853.40 firm fixed-price call under a Blanket Purchase Agreement (BPA) to 10X Genomics, Inc. on May 9, 2024, with completion scheduled for May 8, 2025. The contract procures reagents necessary to support ongoing research into T cell responses to chronic viral infections and cancer. 10X Genomics, a biotechnology company headquartered in Pleasanton, California, specializes in advanced genomic analysis platforms and reagents, including single-cell and...
- The National Cancer Institute (NCI) awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $15,150.50 to 10X Genomics, Inc. on August 28, 2022, with an ultimate completion date of September 27, 2022. The contract, with no set-aside designation, calls for single-cell isolation and sequencing reagents and equipment from tumor and metastatic sites to support cancer research conducted by Jae Young So and Abdul Ahad. The work will be performed at 10X Genomics' facility in...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,102.75 firm fixed price contract to 10X Genomics, Inc. for single cell RNA sequencing on provided RNA samples. 10X Genomics will perform the requested 5' prime single cell RNA sequencing services at their Pleasanton, California facility between February 2nd and 28th, 2023. The National Cancer Institute seeks to advance cancer research and this contract will provide genomic analysis...
- The National Cancer Institute (NCI) awarded a Firm Fixed Price BPA (Blanket Purchase Agreement) Call contract to 10X Genomics, Inc. on July 21, 2023, with a ceiling value of $24,324.00 and an ultimate completion date of December 26, 2023. This contract, which carries no set-aside designation, was performed at 10X Genomics' Pleasanton, California location. As a leading biotechnology company specializing in advanced genomic analysis platforms and reagents, 10X Genomics provides the NCI with...
- The National Cancer Institute awarded a $24,324 firm fixed-price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc. on July 17, 2023, for the procurement of biological kits. The contract was executed without a set-aside designation and is set to complete by August 16, 2023. 10X Genomics, a biotechnology company headquartered in Pleasanton, California, specializes in advanced genomic analysis platforms and reagents, with particular expertise in single-cell and spatial transcriptomics...
- The National Cancer Institute awarded a $16,711.40 firm fixed-price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc. on June 21, 2022, for biological kits. The contract was completed on July 12, 2022, with performance at the contractor's facility in Pleasanton, California. No set-aside designation was used for this procurement. 10X Genomics is a biotechnology company specializing in advanced genomic analysis platforms and reagents, particularly for single-cell and spatial...
- The National Cancer Institute (NCI) awarded a $12,449 firm fixed-price contract to 10X Genomics, Inc. on March 10, 2023, for the procurement of biological kits. This contract was issued as a Blanket Purchase Agreement (BPA) call with an ultimate completion date of April 7, 2023, and does not include a set-aside designation. The prime contractor, 10X Genomics, is headquartered in Pleasanton, California—which also serves as the place of performance—and specializes in advanced genomic analysis...